Cargando…
Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model
BACKGROUND: The knowledge of where particles deposit in the respiratory tract is crucial for understanding the health effects associated with inhaled drug particles. METHOD: An ex vivo study was conducted to assess regional deposition patterns (thoracic vs. extrathoracic) of radioactive polydisperse...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937580/ https://www.ncbi.nlm.nih.gov/pubmed/27388488 http://dx.doi.org/10.1186/s12931-016-0395-7 |
_version_ | 1782441732889116672 |
---|---|
author | Perinel, Sophie Leclerc, Lara Prévôt, Nathalie Deville, Agathe Cottier, Michèle Durand, Marc Vergnon, Jean-Michel Pourchez, Jérémie |
author_facet | Perinel, Sophie Leclerc, Lara Prévôt, Nathalie Deville, Agathe Cottier, Michèle Durand, Marc Vergnon, Jean-Michel Pourchez, Jérémie |
author_sort | Perinel, Sophie |
collection | PubMed |
description | BACKGROUND: The knowledge of where particles deposit in the respiratory tract is crucial for understanding the health effects associated with inhaled drug particles. METHOD: An ex vivo study was conducted to assess regional deposition patterns (thoracic vs. extrathoracic) of radioactive polydisperse aerosols with different size ranges [0.15 μm–0.5 μm], [0.25 μm–1 μm] and [1 μm–9 μm]. SPECT/CT analyses were performed complementary in order to assess more precisely the regional deposition of aerosols within the pulmonary tract. Experiments were set using an original respiratory tract model composed of a human plastinated head connected to an ex vivo porcine pulmonary tract. The model was ventilated by passive expansion, simulating pleural depressions. Aerosol was administered during nasal breathing. RESULTS: Planar scintigraphies allowed to calculate the deposited aerosol fractions for particles in the three size ranges from sub-micron to micron The deposited fractions obtained, for thoracic vs. extra-thoracic regions respectively, were 89 ± 4 % vs. 11 ± 4 % for [0.15 μm–0.5 μm], 78 ± 5 % vs. 22 ± 5 % for [0.25 μm–1 μm] and 35 ± 11 % vs.65 ± 11 % for [1 μm–9 μm]. CONCLUSION: Results obtained with this new ex vivo respiratory tract model are in good agreement with the in vivo data obtained in studies with baboons and humans. |
format | Online Article Text |
id | pubmed-4937580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49375802016-07-09 Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model Perinel, Sophie Leclerc, Lara Prévôt, Nathalie Deville, Agathe Cottier, Michèle Durand, Marc Vergnon, Jean-Michel Pourchez, Jérémie Respir Res Research BACKGROUND: The knowledge of where particles deposit in the respiratory tract is crucial for understanding the health effects associated with inhaled drug particles. METHOD: An ex vivo study was conducted to assess regional deposition patterns (thoracic vs. extrathoracic) of radioactive polydisperse aerosols with different size ranges [0.15 μm–0.5 μm], [0.25 μm–1 μm] and [1 μm–9 μm]. SPECT/CT analyses were performed complementary in order to assess more precisely the regional deposition of aerosols within the pulmonary tract. Experiments were set using an original respiratory tract model composed of a human plastinated head connected to an ex vivo porcine pulmonary tract. The model was ventilated by passive expansion, simulating pleural depressions. Aerosol was administered during nasal breathing. RESULTS: Planar scintigraphies allowed to calculate the deposited aerosol fractions for particles in the three size ranges from sub-micron to micron The deposited fractions obtained, for thoracic vs. extra-thoracic regions respectively, were 89 ± 4 % vs. 11 ± 4 % for [0.15 μm–0.5 μm], 78 ± 5 % vs. 22 ± 5 % for [0.25 μm–1 μm] and 35 ± 11 % vs.65 ± 11 % for [1 μm–9 μm]. CONCLUSION: Results obtained with this new ex vivo respiratory tract model are in good agreement with the in vivo data obtained in studies with baboons and humans. BioMed Central 2016-07-07 2016 /pmc/articles/PMC4937580/ /pubmed/27388488 http://dx.doi.org/10.1186/s12931-016-0395-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Perinel, Sophie Leclerc, Lara Prévôt, Nathalie Deville, Agathe Cottier, Michèle Durand, Marc Vergnon, Jean-Michel Pourchez, Jérémie Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model |
title | Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model |
title_full | Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model |
title_fullStr | Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model |
title_full_unstemmed | Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model |
title_short | Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model |
title_sort | micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937580/ https://www.ncbi.nlm.nih.gov/pubmed/27388488 http://dx.doi.org/10.1186/s12931-016-0395-7 |
work_keys_str_mv | AT perinelsophie micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel AT leclerclara micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel AT prevotnathalie micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel AT devilleagathe micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel AT cottiermichele micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel AT durandmarc micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel AT vergnonjeanmichel micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel AT pourchezjeremie micronsizedandsubmicronsizedaerosoldepositioninanewexvivopreclinicalmodel |